Role of the PI3K/AKT signaling pathway in regulating gene expression in rheumatoid arthritis (Review)

Chengzhi Cong1, Yuan Wang1, Jian Liu1

  • 1Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, P.R. China.

Insights

Rheumatoid arthritis (RA) involves joint inflammation and destruction. This review explores how the PI3K/AKT pathway influences RA gene expression and discusses potential treatments.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease causing synovial inflammation and joint destruction.
  • RA significantly impacts patient quality of life, leading to deformity, functional loss, and disability.
  • The PI3K/AKT signaling pathway is crucial in regulating inflammatory responses, cell survival, and gene expression within RA pathogenesis.

Purpose of the Study:

  • To review the role of the PI3K/AKT pathway in modulating gene expression in rheumatoid arthritis.
  • To summarize the impact of PI3K/AKT on key genes, including cytokines and non-coding RNAs, in RA.
  • To discuss the interactions between PI3K/AKT and other signaling pathways, alongside current RA therapeutic strategies.

Main Methods:

  • Literature review of studies on PI3K/AKT signaling in rheumatoid arthritis.
  • Analysis of research detailing gene expression modulation by PI3K/AKT in RA.
  • Examination of studies on pathway crosstalk and therapeutic interventions for RA.

Main Results:

  • The PI3K/AKT pathway significantly influences the expression of critical genes in RA pathogenesis.
  • Specific cytokines and non-coding RNAs are shown to be modulated by PI3K/AKT signaling in RA.
  • Interactions between PI3K/AKT and other signaling pathways are identified, offering insights into RA mechanisms.

Conclusions:

  • The PI3K/AKT pathway is a key regulator in rheumatoid arthritis, affecting inflammatory and cellular processes.
  • Understanding PI3K/AKT's role in gene expression and pathway crosstalk is vital for developing targeted RA therapies.
  • Further research into PI3K/AKT modulation holds promise for novel therapeutic strategies for rheumatoid arthritis.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...